GlaxoSmithKline, the largest European drug maker, issued a press release this week defending Huntingdon Life Sciences and promised that it would continue to be a customer of HLS despite the concerted campaign of intimidation by animal rights activists against anyone continuing to do business with HLS.
In its press release, GSK chairman Richard Sykes said, “It is totally unacceptable that any company conducting its legitimate business within the confines of the law can be undermined by a long-term campaign of violence, intimidation and harassment.”
Sykes went on to point out that medical progress cannot occur without animal experimentation and that GKS would continue to use HLS as long as it maintained its high standards of animal welfare.
Source:
Glaxo backs beleaguered animal testing lab. Reuters, May 21, 2001.